A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? | The Motley Fool
This ophthalmic pharma specialist -- known for its compounded medications and royalty streams -- just reported a big insider sale.

Source: The Motley Fool
This ophthalmic pharma specialist -- known for its compounded medications and royalty streams -- just reported a big insider sale.